Hepatitis Vaccine Market, Global Outlook and Forecast 2023-2029

Report ID: MMG174976 | Category: Pharma & Healthcare | Pages: 74 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hepatitis vaccine is a vaccine that prevents hepatitis
This report aims to provide a comprehensive presentation of the global market for Hepatitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Vaccine. This report contains market size and forecasts of Hepatitis Vaccine in global, including the following market information:
Global Hepatitis Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hepatitis Vaccine companies in 2022 (%)
The global Hepatitis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatitis A Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis Vaccine include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, by Type, 2022 (%)
    Hepatitis A Vaccines
    Hepatitis B Vaccines
Global Hepatitis Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, by Application, 2022 (%)
    Children
    Adult
Global Hepatitis Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis Vaccine revenues share in global market, 2022 (%)
Key companies Hepatitis Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatitis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    GSK
    NCPC
    Merck
    Bio Kangtai
    Dynavax
    Hissen
    KM Biologics
    LG Life Sciences
    Serum Institute
    Sanofi
    Sinovac
    Zhejiang Pukang
    IMBCA
    ChangSheng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis Vaccine, market overview.
Chapter 2: Global Hepatitis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hepatitis Vaccine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hepatitis Vaccine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hepatitis Vaccine Overall Market Size
    2.1 Global Hepatitis Vaccine Market Size: 2022 VS 2029
    2.2 Global Hepatitis Vaccine Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Hepatitis Vaccine Sales: 2018-2029
3 Company Landscape
    3.1 Top Hepatitis Vaccine Players in Global Market
    3.2 Top Global Hepatitis Vaccine Companies Ranked by Revenue
    3.3 Global Hepatitis Vaccine Revenue by Companies
    3.4 Global Hepatitis Vaccine Sales by Companies
    3.5 Global Hepatitis Vaccine Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Hepatitis Vaccine Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Hepatitis Vaccine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Hepatitis Vaccine Players in Global Market
        3.8.1 List of Global Tier 1 Hepatitis Vaccine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Hepatitis Vaccine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hepatitis Vaccine Market Size Markets, 2022 & 2029
        4.1.2 Hepatitis A Vaccines
        4.1.3 Hepatitis B Vaccines
    4.2 By Type - Global Hepatitis Vaccine Revenue & Forecasts
        4.2.1 By Type - Global Hepatitis Vaccine Revenue, 2018-2023
        4.2.2 By Type - Global Hepatitis Vaccine Revenue, 2024-2029
        4.2.3 By Type - Global Hepatitis Vaccine Revenue Market Share, 2018-2029
    4.3 By Type - Global Hepatitis Vaccine Sales & Forecasts
        4.3.1 By Type - Global Hepatitis Vaccine Sales, 2018-2023
        4.3.2 By Type - Global Hepatitis Vaccine Sales, 2024-2029
        4.3.3 By Type - Global Hepatitis Vaccine Sales Market Share, 2018-2029
    4.4 By Type - Global Hepatitis Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hepatitis Vaccine Market Size, 2022 & 2029
        5.1.2 Children
        5.1.3 Adult
    5.2 By Application - Global Hepatitis Vaccine Revenue & Forecasts
        5.2.1 By Application - Global Hepatitis Vaccine Revenue, 2018-2023
        5.2.2 By Application - Global Hepatitis Vaccine Revenue, 2024-2029
        5.2.3 By Application - Global Hepatitis Vaccine Revenue Market Share, 2018-2029
    5.3 By Application - Global Hepatitis Vaccine Sales & Forecasts
        5.3.1 By Application - Global Hepatitis Vaccine Sales, 2018-2023
        5.3.2 By Application - Global Hepatitis Vaccine Sales, 2024-2029
        5.3.3 By Application - Global Hepatitis Vaccine Sales Market Share, 2018-2029
    5.4 By Application - Global Hepatitis Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Hepatitis Vaccine Market Size, 2022 & 2029
    6.2 By Region - Global Hepatitis Vaccine Revenue & Forecasts
        6.2.1 By Region - Global Hepatitis Vaccine Revenue, 2018-2023
        6.2.2 By Region - Global Hepatitis Vaccine Revenue, 2024-2029
        6.2.3 By Region - Global Hepatitis Vaccine Revenue Market Share, 2018-2029
    6.3 By Region - Global Hepatitis Vaccine Sales & Forecasts
        6.3.1 By Region - Global Hepatitis Vaccine Sales, 2018-2023
        6.3.2 By Region - Global Hepatitis Vaccine Sales, 2024-2029
        6.3.3 By Region - Global Hepatitis Vaccine Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Hepatitis Vaccine Revenue, 2018-2029
        6.4.2 By Country - North America Hepatitis Vaccine Sales, 2018-2029
        6.4.3 US Hepatitis Vaccine Market Size, 2018-2029
        6.4.4 Canada Hepatitis Vaccine Market Size, 2018-2029
        6.4.5 Mexico Hepatitis Vaccine Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Hepatitis Vaccine Revenue, 2018-2029
        6.5.2 By Country - Europe Hepatitis Vaccine Sales, 2018-2029
        6.5.3 Germany Hepatitis Vaccine Market Size, 2018-2029
        6.5.4 France Hepatitis Vaccine Market Size, 2018-2029
        6.5.5 U.K. Hepatitis Vaccine Market Size, 2018-2029
        6.5.6 Italy Hepatitis Vaccine Market Size, 2018-2029
        6.5.7 Russia Hepatitis Vaccine Market Size, 2018-2029
        6.5.8 Nordic Countries Hepatitis Vaccine Market Size, 2018-2029
        6.5.9 Benelux Hepatitis Vaccine Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Hepatitis Vaccine Revenue, 2018-2029
        6.6.2 By Region - Asia Hepatitis Vaccine Sales, 2018-2029
        6.6.3 China Hepatitis Vaccine Market Size, 2018-2029
        6.6.4 Japan Hepatitis Vaccine Market Size, 2018-2029
        6.6.5 South Korea Hepatitis Vaccine Market Size, 2018-2029
        6.6.6 Southeast Asia Hepatitis Vaccine Market Size, 2018-2029
        6.6.7 India Hepatitis Vaccine Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Hepatitis Vaccine Revenue, 2018-2029
        6.7.2 By Country - South America Hepatitis Vaccine Sales, 2018-2029
        6.7.3 Brazil Hepatitis Vaccine Market Size, 2018-2029
        6.7.4 Argentina Hepatitis Vaccine Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Hepatitis Vaccine Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Hepatitis Vaccine Sales, 2018-2029
        6.8.3 Turkey Hepatitis Vaccine Market Size, 2018-2029
        6.8.4 Israel Hepatitis Vaccine Market Size, 2018-2029
        6.8.5 Saudi Arabia Hepatitis Vaccine Market Size, 2018-2029
        6.8.6 UAE Hepatitis Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 GSK
        7.1.1 GSK Company Summary
        7.1.2 GSK Business Overview
        7.1.3 GSK Hepatitis Vaccine Major Product Offerings
        7.1.4 GSK Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.1.5 GSK Key News & Latest Developments
    7.2 NCPC
        7.2.1 NCPC Company Summary
        7.2.2 NCPC Business Overview
        7.2.3 NCPC Hepatitis Vaccine Major Product Offerings
        7.2.4 NCPC Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.2.5 NCPC Key News & Latest Developments
    7.3 Merck
        7.3.1 Merck Company Summary
        7.3.2 Merck Business Overview
        7.3.3 Merck Hepatitis Vaccine Major Product Offerings
        7.3.4 Merck Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.3.5 Merck Key News & Latest Developments
    7.4 Bio Kangtai
        7.4.1 Bio Kangtai Company Summary
        7.4.2 Bio Kangtai Business Overview
        7.4.3 Bio Kangtai Hepatitis Vaccine Major Product Offerings
        7.4.4 Bio Kangtai Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.4.5 Bio Kangtai Key News & Latest Developments
    7.5 Dynavax
        7.5.1 Dynavax Company Summary
        7.5.2 Dynavax Business Overview
        7.5.3 Dynavax Hepatitis Vaccine Major Product Offerings
        7.5.4 Dynavax Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.5.5 Dynavax Key News & Latest Developments
    7.6 Hissen
        7.6.1 Hissen Company Summary
        7.6.2 Hissen Business Overview
        7.6.3 Hissen Hepatitis Vaccine Major Product Offerings
        7.6.4 Hissen Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.6.5 Hissen Key News & Latest Developments
    7.7 KM Biologics
        7.7.1 KM Biologics Company Summary
        7.7.2 KM Biologics Business Overview
        7.7.3 KM Biologics Hepatitis Vaccine Major Product Offerings
        7.7.4 KM Biologics Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.7.5 KM Biologics Key News & Latest Developments
    7.8 LG Life Sciences
        7.8.1 LG Life Sciences Company Summary
        7.8.2 LG Life Sciences Business Overview
        7.8.3 LG Life Sciences Hepatitis Vaccine Major Product Offerings
        7.8.4 LG Life Sciences Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.8.5 LG Life Sciences Key News & Latest Developments
    7.9 Serum Institute
        7.9.1 Serum Institute Company Summary
        7.9.2 Serum Institute Business Overview
        7.9.3 Serum Institute Hepatitis Vaccine Major Product Offerings
        7.9.4 Serum Institute Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.9.5 Serum Institute Key News & Latest Developments
    7.10 Sanofi
        7.10.1 Sanofi Company Summary
        7.10.2 Sanofi Business Overview
        7.10.3 Sanofi Hepatitis Vaccine Major Product Offerings
        7.10.4 Sanofi Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.10.5 Sanofi Key News & Latest Developments
    7.11 Sinovac
        7.11.1 Sinovac Company Summary
        7.11.2 Sinovac Hepatitis Vaccine Business Overview
        7.11.3 Sinovac Hepatitis Vaccine Major Product Offerings
        7.11.4 Sinovac Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.11.5 Sinovac Key News & Latest Developments
    7.12 Zhejiang Pukang
        7.12.1 Zhejiang Pukang Company Summary
        7.12.2 Zhejiang Pukang Hepatitis Vaccine Business Overview
        7.12.3 Zhejiang Pukang Hepatitis Vaccine Major Product Offerings
        7.12.4 Zhejiang Pukang Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.12.5 Zhejiang Pukang Key News & Latest Developments
    7.13 IMBCA
        7.13.1 IMBCA Company Summary
        7.13.2 IMBCA Hepatitis Vaccine Business Overview
        7.13.3 IMBCA Hepatitis Vaccine Major Product Offerings
        7.13.4 IMBCA Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.13.5 IMBCA Key News & Latest Developments
    7.14 ChangSheng
        7.14.1 ChangSheng Company Summary
        7.14.2 ChangSheng Business Overview
        7.14.3 ChangSheng Hepatitis Vaccine Major Product Offerings
        7.14.4 ChangSheng Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
        7.14.5 ChangSheng Key News & Latest Developments
8 Global Hepatitis Vaccine Production Capacity, Analysis
    8.1 Global Hepatitis Vaccine Production Capacity, 2018-2029
    8.2 Hepatitis Vaccine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Hepatitis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Hepatitis Vaccine Supply Chain Analysis
    10.1 Hepatitis Vaccine Industry Value Chain
    10.2 Hepatitis Vaccine Upstream Market
    10.3 Hepatitis Vaccine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Hepatitis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hepatitis Vaccine Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?